Treatment-related MDS, also
known as secondary MDS, makes up a small fraction of cases of MDS. It is most
commonly seen in patients who have been previously treated for cancer with
chemotherapy or radiation therapy.
During this program, recorded on May 26, 2016, Dr. Walker uses case studies to explain and help you understand secondary MDS. She begins by briefly explaining the risk factors and causes involved in developing secondary MDS and defines symptoms you may experience upon diagnosis. Dr. Walker also goes over possible treatment options for secondary MDS such as hypomethylating agents, immunosuppressive therapies, supportive care, and stem cell transplantation.
By the end of this program, you will understand:
- The difference between primary (de novo) and secondary MDS
- Factors that could possibly affect treatment response
- The two general categories of secondary MDS (MDS arising from or associated with another primary bone marrow disorder vs. therapy-related MDS)
- How to play an active role in your care by monitoring your condition and communicating with your medical team
- Click the presentation link down below
- Select Resources tab
- Download PDF of transcription